SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells

Epidermal Growth Factor (EGF) receptor overexpression, KRAS, TP53, CDKN2A and SMAD4 mutations characterize pancreatic ductal adenocarcinoma. This mutational landscape might influence cancer cells response to EGF, Transforming Growth Factor β1 (TGFβ1) and stromal inflammatory calcium binding proteins...

Descripción completa

Detalles Bibliográficos
Autores principales: Moz, Stefania, Basso, Daniela, Bozzato, Dania, Galozzi, Paola, Navaglia, Filippo, Negm, Ola H., Arrigoni, Giorgio, Zambon, Carlo-Federico, Padoan, Andrea, Tighe, Paddy, Todd, Ian, Franchin, Cinzia, Pedrazzoli, Sergio, Punzi, Leonardo, Plebani, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342525/
https://www.ncbi.nlm.nih.gov/pubmed/27655713
http://dx.doi.org/10.18632/oncotarget.12068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342525/
https://www.ncbi.nlm.nih.gov/pubmed/27655713
http://dx.doi.org/10.18632/oncotarget.12068

Ejemplares similares